-
GLP-1 Therapy Part 1: Setting Realistic Weight Loss Expectations
I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment. This premier event, dedicated to supporting nutrition and dietetics professionals in Colorado, offered a valuable opportunity to share updated evidence on GLP-1 therapies, while also debunking common myths to promote informed and unbiased nutrition counseling. In this four-part series, I’m excited to share my key recommendations to help support your practice. In Part 1, we’ll explore key considerations for identifying appropriate GLP-1 candidates and highlight the importance of setting realistic…
-
Dizziness and Wegovy: What’s the Connection?
I’ve recently had an increasing number of patients report dizziness while taking Wegovy (semaglutide). This has been observed in both newly prescribed patients and those who have been on the medication for over a year. The dizziness appears distinct from more common side effects such as nausea, vomiting, diarrhea, and constipation. It occurs suddenly and unpredictably but is consistently present. What could be causing this dizziness in patients using Wegovy for weight loss? Let’s explore the science to better understand this phenomenon. What is Wegovy? Wegovy is a once weekly prescription medication containing semaglutide, which is used for chronic weight…
-
Mitigating Therapeutic Inertia of GLP-1 Use in T2D
Glucagon-like peptide-1 receptor agonists, commonly known as GLP-1 RAs, have recently garnered significant media attention. Initially developed to improve glycemic control in patients with type 2 diabetes, these medications have also proven to be highly effective for weight loss and enhancing cardiovascular health. However, without proper initiation, titration, and support from the care team, they can often be ineffective and unsustainable. Patients can become stuck in therapeutic inertia. I had the pleasure of presenting on this topic with a pharmacy colleague at this year’s ADCES Annual Conference for diabetes care and education specialists. Here’s how we identified and provided solutions…
-
GLP-1 Injectables for Older Adults
With the increasing interest in and popularity of GLP-1 injectable medications, there is a growing concern about their safety when used with older adults. This article reviews some of the benefits and concerns associated with the use of GLP-1 injectable medications in advanced age. Are GLP-1’s Appropriate for Older Adults? In general, age is not a contraindication to using GLP-1 medications. Individuals of any age can experience weight loss and improved metabolic health with a once-weekly injectable. In fact, medications like Ozempic or Trulicity can be safer options compared to others such as insulin or sulfonylureas, as they rarely cause…
